A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women

BACKGROUND: Reducing the dose of efavirenz can improve safety, reduce costs, and increase access for patients with HIV infection. According to the World Health Organization, a similar dosing strategy for all patient populations is desirable for universal roll-out; however, it remains unknown whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Schalkwijk, Stein, ter Heine, Rob, Colbers, Angela C., Huitema, Alwin D. R., Denti, Paolo, Dooley, Kelly E., Capparelli, Edmund, Best, Brookie M., Cressey, Tim R., Greupink, Rick, Russel, Frans G. M., Mirochnick, Mark, Burger, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182466/
https://www.ncbi.nlm.nih.gov/pubmed/29520730
http://dx.doi.org/10.1007/s40262-018-0642-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182466/
https://www.ncbi.nlm.nih.gov/pubmed/29520730
http://dx.doi.org/10.1007/s40262-018-0642-9

Ejemplares similares